Fiona Lynott
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fiona Lynott has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Aisling Spillane
Cancer Molecular Diagnostics Department, Saint James Hospital, D08 NHY1 Dublin, Ireland
1 shared publication - Anna Keogh
Department of Histopathology, St. James’s Hospital, Dublin, Ireland
1 shared publication - Antonios Papanicolau-Sengos
Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
1 shared publication - Elaine S. Jaffe
National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States
1 shared publication - Ezzat Elhassadi
Department of Haematology University Hospital Waterford Waterford Ireland
1 shared publication - Fiona Quinn
Cancer Molecular Diagnostics Department, Saint James Hospital, D08 NHY1 Dublin, Ireland
1 shared publication
Latest Publications
- Open Access
- 15 November 2022
- Published by MDPI AG in Hematology Reports
- Vol. 14 (4) , 335-341
An Isolated Mesenteric Presentation of a Nodal Peripheral T Cell Lymphoma with T Follicular Helper Cell Phenotype
Nodal peripheral T cell lymphoma (PTCL) with T follicular helper (TFH) cell phenotype is a provisional entity added to the 2016 revised WHO classification of haematological malignancies. These lymphomas have an aggressive clinical course and respond poorly to conventional treatments. Distinct histological features have not been well described. Additionally, the minimum criteria for diagnosis is not well established but detection of at least two TFH markers in addition to CD4 is suggested to assign a TFH cell phenotype. Some pathological features of angioimmunoblastic T cell lymphoma (AITL) such as recurrent molecular alterations are commonly found. As the name suggests, these lymphomas are nodal in origin with patients presenting with widespread lymphadenopathy. We describe the first documented case of nodal PTCL with a TFH phenotype presenting as an isolated mesenteric mass with no nodal involvement.
- 15 November 2022
- Published by MDPI AG in Hematology Reports
- Vol. 14 (4) , 335-341
Open AccessAn Isolated Mesenteric Presentation of a Nodal Peripheral T Cell Lymphoma with T Follicular Helper Cell Phenotype
Nodal peripheral T cell lymphoma (PTCL) with T follicular helper (TFH) cell phenotype is a provisional entity added to the 2016 revised WHO classification of haematological malignancies. These lymphomas have an aggressive clinical course and respond poorly to conventional treatments. Distinct histological features have not been well described. Additionally, the minimum criteria for diagnosis is not well established but detection of at least two TFH markers in addition to CD4 is suggested to assign a TFH cell phenotype. Some pathological features of angioimmunoblastic T cell lymphoma (AITL) such as recurrent molecular alterations are commonly found. As the name suggests, these lymphomas are nodal in origin with patients presenting with widespread lymphadenopathy. We describe the first documented case of nodal PTCL with a TFH phenotype presenting as an isolated mesenteric mass with no nodal involvement.